Drug Development

Articles

Corning will feature its 3D bioprinting technology and tools to support 3D cell culture at booth #1029 during the SLAS 2018 conference on Feb. 3-7, 2018 in San Diego, CA.

Corning Showcases 3D Cell Culture Technologies at SLAS 2018

Comecar will provide cell culture equipment for biopharmaceutical company CO.DON AG's new production site in Leipzig, Germany.

Comecar in $12-Million Deal to Equip German Cell Culture Lab

Hovione has installed a new MG2 Tekna Precision Capsule filler at its Portugal site.

Hovione Adds New Capsule Filler at Portugal Site

Growth is expected for the generic drugs and biosimilars sectors, driven by cost pressures on healthcare systems.

CPhI Report Predicts A Transformative Year for Japan in 2018

Frustrated with chronic shortages and high costs, hospitals form their own generic drug company.

Hospitals Launch Their Own Generic Drug Company

The company is developing a pipeline of combination therapies using its patented polymer-based matrix delivery system, known as TAOS (targeted orchestrated signalling matrix).

Locate Therapeutics Achieves ISO 13845 Certification for Development and Control of Manufacturing for Resorbable Biomaterials

The US Government Accountability Office released a report stating that FDA should make its plans to release guidance regarding nonbiological complex drugs public.

GAO Report Calls for FDA to Publicly Announce Guidance on Nonbiological Complex Drugs

The acquisition, valued at EUR 520 million (US$631 million), would expand Takeda’s late-stage pipeline in gastroenterology and would extend an already existing collaboration between the two companies.

Takeda to Acquire TiGenix

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Graham Reynolds, vice-president and general manager, Global Biologics at West Pharmaceutical Services, Inc., shares insights on key considerations when developing a biologic drug product in a prefilled syringe. 

Formulation and Functional Considerations for Delivering Biologics in Prefilled Syringes

The companies aim to develop a potential zinc finger protein transcription factor-based gene therapy for treating Lou Gehrig’s disease.

Formulation and Drug Delivery